Real-world effectiveness of golimumab in the treatment of patients with active rheumatoid arthritis, psoriatic arthritis, or axial spondyloarthritis who failed initial TNF-α inhibitor therapy: a pooled analysis of European prospective observational studie (2024)
https://pubmed.ncbi.nlm.nih.gov/37976120/

An international multi-centre analysis of current prescribing practices and shared decision-making in psoriatic arthritis (2024)
https://pubmed.ncbi.nlm.nih.gov/38011669/

Management of psoriatic arthritis: a consensus opinion by expert rheumatologists (2024)
https://pubmed.ncbi.nlm.nih.gov/38098852/

How do patient reported outcome measures affect treatment intensification and patient satisfaction in the management of psoriatic arthritis? A cross sectional study of 503 patients (2024)
https://pubmed.ncbi.nlm.nih.gov/38191998/

Assessment of Patient-Physician Interactions in Psoriatic Arthritis: National Results of the ASSIST Study (2024)
https://pubmed.ncbi.nlm.nih.gov/38446398/

The management of patients with inflammatory bowel disease-associated spondyloarthritis: Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Society of Rheumatology (SIR) recommendations based on a pseudo-Delphi consensus (2024)
https://pubmed.ncbi.nlm.nih.gov/38521214/

Management of Dactylitis in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations (2023)
https://pubmed.ncbi.nlm.nih.gov/36319013/

Morphologic, dynamic and high-resolution microscopy MRI in early-onset spondyloarthritis finger dactylitis (2023)
https://pubmed.ncbi.nlm.nih.gov/36331575/

Axial Spondyloarthritis: Reshape the Future-From the “2022 GISEA International Symposium (2023)
https://pubmed.ncbi.nlm.nih.gov/36556152/

Residual Disease in Patients with Axial Spondyloarthritis: A Post-Hoc Analysis of the QUASAR Study (2022)
https://pubmed.ncbi.nlm.nih.gov/35743623/

Effectiveness of Golimumab as Second Anti-TNFα Drug in Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Axial Spondyloarthritis in Italy: GO-BEYOND, a Prospective Real-World Observational Study (2022)
https://pubmed.ncbi.nlm.nih.gov/35887946/

Quality of life and therapeutic management of axial spondyloarthritis patients in Italy: a 12-month prospective observational study. (2021)
https://pubmed.ncbi.nlm.nih.gov/33427620/

Secukinumab in patients with psoriatic arthritis and axial manifestations: results from the double-blind, randomised, phase 3 MAXIMISE trial (2020)
https://pubmed.ncbi.nlm.nih.gov/33334727/

Toxicological considerations in the treatment of axial spondylo-arthritis. (2020)
https://pubmed.ncbi.nlm.nih.gov/32755721/

Toxicological considerations in the treatment of axial spondylo-arthritis. (2020)
https://pubmed.ncbi.nlm.nih.gov/32552128/

Toxicological considerations in the treatment of axial spondylo-arthritis. (2020)
https://pubmed.ncbi.nlm.nih.gov/32552128/